| New |
| Code |
Description |
| G8996 |
Swallowing functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G8997 |
Swallowing functional limitation, projected goal status, at initial therapy treatment/outset and at discharge from therapy |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy/end of reporting on limitation |
| G8999 |
Motor speech functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9158 |
Motor speech functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9159 |
Spoken language comprehension functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9160 |
Spoken language comprehension functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9161 |
Spoken language comprehension functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9162 |
Spoken language expression functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9163 |
Spoken language expression functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9164 |
Spoken language expression functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9171 |
Voice functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9172 |
Voice functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9173 |
Voice functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9174 |
Other speech language pathology functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9175 |
Other speech language pathology functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9176 |
Other speech language pathology functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9186 |
Motor speech functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| V5281 |
Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type |
| V5282 |
Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type |
| V5283 |
Assistive listening device, personal fm/dm neck, loop induction receiver |
| V5284 |
Assistive listening device, personal fm/dm, ear level receiver |
| V5285 |
Assistive listening device, personal fm/dm, direct audio input receiver |
| V5286 |
Assistive listening device, personal blue tooth fm/dm receiver |
| V5287 |
Assistive listening device, personal fm/dm receiver, not otherwise specified |
| V5288 |
Assistive listening device, personal fm/dm transmitter assistive listening device |
| V5289 |
Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type |
| V5290 |
Assistive listening device, transmitter microphone, any type |
| C9742 |
Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed |
| G9463 |
I intend to report the sinusitis measures group |
| G9464 |
All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient |
| G9465 |
I intend to report the acute otitis externa (aoe) measures group |
| G9466 |
All quality actions for the applicable measures in the aoe measures group have been performed for this patient |
| G9467 |
Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills |
| G9552 |
Incidental thyroid nodule < 1.0 cm noted in report |
| G9553 |
Prior thyroid disease diagnosis |
| J0596 |
Injection, C1 esterase inhibitor (recombinant), ruconest, 10 units |
| J1833 |
Injection, isavuconazonium, 1 mg |
| J2547 |
Injection, peramivir, 1 mg |
| L8607 |
Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies |
| G9703 |
Children who are taking antibiotics in the 30 days prior to the diagnosis of pharyngitis |
| G9712 |
Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis |
| J7342 |
Installation, ciprofloxacin otic suspension, 6 mg |
| L8625 |
External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each |
| L8694 |
Auditory osseointegrated device, transducer/actuator, replacement only, each |
